Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy

被引：0
|
作者：
Alison M. Pease
Luis A. Riba
Ryan A. Gruner
Nadine M. Tung
Ted A. James
机构：
[1] Harvard Medical School,Department of Surgery, Beth Israel Deaconess Medical Center
[2] Harvard Medical School,Department of Surgery/Linsey BreastCare Center, Beth Israel Deaconess Medical Center
[3] Harvard Medical School,Department of Medicine/Division of Hematology – Oncology, Beth Israel Deaconess Medical Center
来源：
Annals of Surgical Oncology | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：366 / 371
页数：5
相关论文
共 50 条
  • [1] Oncotype DX® recurrence score as a predictor of response to neoadjuvant chemotherapy
    Riba, Luis
    Gruner, Ryan
    Tung, Nadine
    James, Ted
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 264 - 264
  • [2] Oncotype DXA® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy
    Pease, Alison M.
    Riba, Luis A.
    Gruner, Ryan A.
    Tung, Nadine M.
    James, Ted A.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (02) : 366 - 371
  • [3] The Role of Oncotype DX® Recurrence Score in Predicting Axillary Response After Neoadjuvant Chemotherapy in Breast Cancer
    Jaime A. Pardo
    Betty Fan
    Alessandra Mele
    Stephanie Serres
    Monica G. Valero
    Isha Emhoff
    Amulya Alapati
    Ted A. James
    Annals of Surgical Oncology, 2021, 28 : 1320 - 1325
  • [4] Role of Oncotype DX® recurrence score in predicting nodal response after neoadjuvant chemotherapy in breast cancer
    Mele, Alessandra
    Alapati, Amulya
    James, Ted
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : 172 - 172
  • [5] The Warwick Experience of the Oncotype DX® Breast Recurrence Score® Assay as a Predictor of Chemotherapy Administration
    Khan, Mashuk Alam
    Henderson, Laura
    Clarke, Dayalan
    Harries, Simon
    Jones, Lucie
    BREAST CARE, 2018, 13 (05) : 369 - 372
  • [6] The Role of Oncotype DX(R) Recurrence Score in Predicting Axillary Response After Neoadjuvant Chemotherapy in Breast Cancer
    Pardo, Jaime A.
    Fan, Betty
    Mele, Alessandra
    Serres, Stephanie
    Valero, Monica G.
    Emhoff, Isha
    Alapati, Amulya
    James, Ted A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (03) : 1320 - 1325
  • [7] Prediction of response to neoadjuvant chemotherapy in ER plus breast cancer: Magee equation recurrence versus oncotype DX® recurrence score
    Soran, A.
    Johnson, R.
    Menekse, E.
    Bhargava, R.
    McGuire, K.
    McAuliffe, P.
    Ahrendt, G.
    Dabbs, D.
    Bonaventura, M.
    CANCER RESEARCH, 2016, 76
  • [8] Oncotype DX Recurrence Score in premenopausal women
    Zhang, Shiliang
    Fitzsimmons, Kasey C.
    Hurvitz, Sara A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [9] Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?
    Jeffrey G. Schneider
    Danny N. Khalil
    Breast Cancer Research and Treatment, 2012, 134 : 1125 - 1132
  • [10] Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?
    Schneider, Jeffrey G.
    Khalil, Danny N.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (03) : 1125 - 1132
12345